168 related articles for article (PubMed ID: 19289095)
41. A bioactive drug quantitation based approach for the detection of anti-drug neutralizing antibodies in human serum.
Hu J; Gupta S; Swanson SJ; Zhuang Y
J Immunol Methods; 2009 Jun; 345(1-2):70-9. PubMed ID: 19375427
[TBL] [Abstract][Full Text] [Related]
42. Glutamine deamidation of a recombinant monoclonal antibody.
Liu H; Gaza-Bulseco G; Chumsae C
Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4081-8. PubMed ID: 19021137
[TBL] [Abstract][Full Text] [Related]
43. A critical review of analytical ultracentrifugation and field flow fractionation methods for measuring protein aggregation.
Liu J; Andya JD; Shire SJ
AAPS J; 2006 Sep; 8(3):E580-9. PubMed ID: 17025276
[TBL] [Abstract][Full Text] [Related]
44. Effects of rotational speed on the hydrodynamic properties of pharmaceutical antibodies measured by analytical ultracentrifugation sedimentation velocity.
Krayukhina E; Uchiyama S; Fukui K
Eur J Pharm Sci; 2012 Sep; 47(2):367-74. PubMed ID: 22728396
[TBL] [Abstract][Full Text] [Related]
45. Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation.
Bou-Assaf GM; Budyak IL; Brenowitz M; Day ES; Hayes D; Hill J; Majumdar R; Ringhieri P; Schuck P; Lin JC
J Pharm Sci; 2022 Jul; 111(7):2121-2133. PubMed ID: 34986360
[TBL] [Abstract][Full Text] [Related]
46. Generation, Characterization, and Quantitative Bioanalysis of Drug/Anti-drug Antibody Immune Complexes to Facilitate Dedicated In Vivo Studies.
Hoffmann E; Jordan G; Lauer M; Ringler P; Kusznir EA; Rufer AC; Huber S; Jochner A; Winter G; Staack RF
Pharm Res; 2019 Jun; 36(9):129. PubMed ID: 31254106
[TBL] [Abstract][Full Text] [Related]
47. Sedimentation velocity FDS studies of antibodies in pooled human serum.
Correia JJ; Bishop GR; Kyle PB; Wright RT; Sherwood PJ; Stafford WF
Eur Biophys J; 2023 Jul; 52(4-5):321-332. PubMed ID: 37160443
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibody pharmacokinetics and pharmacodynamics.
Wang W; Wang EQ; Balthasar JP
Clin Pharmacol Ther; 2008 Nov; 84(5):548-58. PubMed ID: 18784655
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
50. Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics.
Strauss DM; Lute S; Tebaykina Z; Frey DD; Ho C; Blank GS; Brorson K; Chen Q; Yang B
Biotechnol Bioeng; 2009 Oct; 104(2):371-80. PubMed ID: 19575414
[TBL] [Abstract][Full Text] [Related]
51. SEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix.
Boysen M; Schlicksupp L; Dreher I; Loebbert R; Richter M
J Immunol Res; 2016; 2016():9096059. PubMed ID: 27556050
[TBL] [Abstract][Full Text] [Related]
52. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
53. Omalizumab: overview of pharmacology and efficacy in asthma.
Ledford DK
Expert Opin Biol Ther; 2009 Jul; 9(7):933-43. PubMed ID: 19527111
[TBL] [Abstract][Full Text] [Related]
54. Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes.
Poungpair O; Chaicumpa W; Kulkeaw K; Maneewatch S; Thueng-in K; Srimanote P; Tongtawe P; Songserm T; Lekcharoensuk P; Tapchaisri P
J Virol Methods; 2009 Jul; 159(1):105-11. PubMed ID: 19442853
[TBL] [Abstract][Full Text] [Related]
55. Rapid, antibody-free detection of recombinant proteins on blots using enzyme fragment complementation.
Charter NW; Horecka J; Loh CY; Doan A; Wehrman T; Olson KR
Methods Mol Biol; 2009; 536():395-405. PubMed ID: 19378077
[TBL] [Abstract][Full Text] [Related]
56. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
[TBL] [Abstract][Full Text] [Related]
57. Aggregation-associated loss of antigenicity observed for denatured virion protein 1 of Equine rhinitis A virus in an enzyme-linked immunosorbent assay.
Kriegshäuser G; Kuechler E; Skern T
Virus Res; 2009 Jul; 143(1):130-3. PubMed ID: 19463730
[TBL] [Abstract][Full Text] [Related]
58. Microheterogeneous monoclonal antibody subspecies with differential hepatitis C virus core antigen binding properties identified by SEC-HPLC.
Muerhoff AS; Rupprecht K; Ruan Q; Zeck B; Ramsay C; Zhao C; Desai SM
J Immunol Methods; 2009 Jun; 345(1-2):60-9. PubMed ID: 19375428
[TBL] [Abstract][Full Text] [Related]
59. A study on the temperature dependency and time course of the cold capture antibody secretion assay.
Pichler J; Hesse F; Wieser M; Kunert R; Galosy SS; Mott JE; Borth N
J Biotechnol; 2009 Apr; 141(1-2):80-3. PubMed ID: 19428734
[TBL] [Abstract][Full Text] [Related]
60. N-Succinyl-chitosan grafted with low molecular weight polyethylenimine as a serum-resistant gene vector.
Lu B; Sun YX; Li YQ; Zhang XZ; Zhuo RX
Mol Biosyst; 2009 Jun; 5(6):629-37. PubMed ID: 19462020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
